madman
Super Moderator
In this insightful presentation, Dr. Leon Telis examines the evolving evidence behind testosterone replacement therapy (TRT) in men with prostate cancer.
Once considered unsafe, TRT is now supported by growing research showing that it can be both safe and beneficial for select patients following definitive cancer treatment or during active surveillance.
Dr. Telis reviews historical perspectives, landmark studies, and current guidelines, highlighting how the medical community’s understanding of hormonal balance and cancer survivorship has shifted dramatically over the past two decades.
Key topics include:
* The history of testosterone and prostate cancer research
* Modern evidence supporting TRT safety after radical prostatectomy or radiation
* Considerations for men on active surveillance
* The importance of individualized counseling and follow-up
“The belief that testosterone therapy is dangerous for men with prostate cancer has been gradually replaced by the understanding that, when guided by evidence and proper counseling, it can be both safe and restorative.
”Watch now to explore how science is redefining hormonal health in prostate cancer care.
Conclusions
